Additionally, our conclusions represent, on the one hand, a strong premise for including in future analysis of human T-ALL patients the potential influence on the immune environment exerted by the combined deregulation of the Notch and NF-κB signaling pathways inside tumor T-cells. The gene discussed is NFKB1; the disease is neoplasm.